Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
This article explains the data types used in index level calculations, from price data to breadth indicators, and how each input influences the final level.
28,296 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Investors woke up to a surprising move in CoreWeave stock Monday. The rally hinges on a trail of AI hardware mileston...
Two tech giants sit at the edge of unprecedented scale. This article weighs Nvidia and Alphabet's growth engines, eva...
The weight loss drug space has become a focus for growth-minded investors. This guide weighs Eli Lilly's proven progr...
Palantir has a unique data platform and government-commercial mix. This guide outlines how the business could evolve,...
Alphabet reports results after the bell, but the line that matters most might be capex. This guide shows how data-cen...
Despite a 2026 pullback, Advanced Micro Devices still shows fundamental strength in data-center AI demand and a diver...
RF Industries (RFIL) faces a mix of aerospace, medical, and data-communications demand in 2026. This guide breaks dow...
Artificial intelligence (ai) is moving from pilot projects to mission-critical software. This article examines a lead...
Investors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
Pitney Bowes is navigating a pivot from legacy mailing services to software, data, and commerce solutions. This break...
As AI accelerates, data centers and their support systems become the real backbone of growth. This article breaks dow...